Neurotrope, Inc. announced that the last patient has been dosed in its Phase 2a clinical trial of Bryostatin-1 for the treatment of patients with Alzheimer's disease (AD). The trial is being conducted under an Investigational New Drug (IND) applicat ...
One of the most rapidly fast-tracked vaccines in history—an anti-Ebola “ChAd3” vaccine—just entered clinical trial in humans. It may wrap in November. It protected macaques for five weeks, leaping to 10 months when followed by a booster two months l ...
Georgia's governor is pushing clinical trials for a marijuana-derived drug that proponents say could help treat severe seizure disorders among children, an unlikely election-year move for a Republican in a conservative part of the country that is ju ...
Researchers at the Cleveland Clinic Lou Ruvo Center for Brain Health have conducted the first-ever analysis of clinical trials for Alzheimer’s disease (AD), revealing an urgent need to increase the number of agents entering the AD drug development p ...
Clinical Trials Markedly Improved Public Perception inVentiv Clinical Trial Recruitment Solutions (iCTRS), created to accelerate trials, in collaboration with The Center for Information and Study on Clinical Research Participation (CISCRP) has releas ...
EVENT ANNOUNCEMENT Fomat Medical Research will be acting as a sponsor in the 23rd annual conference organized by Partnerships in Clinical Trials. Fomat is a site management organization (SMO) specialized in the development and management of clinical ...
